Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MACY''S, INC. (M)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 0
  • 1 comments

Macy’s, Inc. to Participate in 6th Annual Evercore Consumer and Retail Conference

Market reaction Comment Full text

ZHENGYE BIOTECHNOLOGY HOLDING LTD (ZYBT)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 7
  • 1 comments

Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Market reaction Comment Full text

INFLECTION POINT ACQUISITION CORP. IV (MRLN)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 1
  • 1 comments

Merlin Successfully Completes Critical Design Review for C-130J Autonomy Program with USSOCOM

Market reaction Comment Full text

BITFARMS LTD (KEEL)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 4
  • 1 comments

Keel Infrastructure Announces Proposed Offering of $350 Million of Convertible Senior Notes

Market reaction Comment Full text

WD 40 CO (WDFC)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 1
  • 1 comments

WD-40 Company Announces Executive Leadership Appointments

Market reaction Comment Full text

AZITRA, INC. (AZTR)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 5
  • 1 comments

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

Market reaction Comment Full text

CIMPRESS PLC (CMPR)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 4
  • 1 comments

Cimpress Announces Closing of $1.1 Billion Term Loan B Maturing in 2033

Market reaction Comment Full text

HIGHWOODS PROPERTIES, INC. (HIW)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 1
  • 1 comments

Highwoods Recasts $150M Unsecured Bank Term Loan

Market reaction Comment Full text

ROOT, INC. (ROOT)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 5
  • 1 comments

Root and Hugo Partner to Expand Access to Affordable Car Insurance for Drivers Seeking Greater Flexibility

Market reaction Comment Full text

LYELL IMMUNOPHARMA, INC. (LYEL)

  • Business News
  • June 04, 2026, 20:05 UTC
  • 1
  • 1 comments

Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress

Market reaction Comment Full text
  • Previous
  • 2300
  • 2301
  • 2302
  • 2303
  • 2304
  • Next

Search

News categories

  • Technical Exchange News(13899)
  • Event(6229)
  • SEC News(351401)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(212507)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin